Joseph Franses, MD
Hematology & Oncology · Chicago, ILNPI 1861830416
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $168,083 of the $190,835 with a category attached, or 88.1%. Foundation Medicine, Inc. accounts for 89.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $44,250 and has fallen 89.8% since, to $4,520 in 2025. Among hematology & oncology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $2687.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Foundation Medicine, Inc.$171K
- Genentech USA, Inc.$9K
- Servier Bioinnovation$4K
- Eisai Inc.$2K
- Boehringer Ingelheim$2K
- E.r. Squibb & Sons, L.L.C.$2K
- plus $768 from 2 others
Across 135 payments — averaging $7273.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$318K
- Eisai Inc.$203K
- Genentech, Inc.$197K
- Bayer$142K
- Merck$60K
- Alnylam Pharmaceuticals Inc.$39K
- plus $24K from 2 others
What the payments were for
- Consulting fees$168,08388%
- Speaking & faculty fees$21,64511%
- Food & beverage$1,1081%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Foundation Medicine, Inc. | 54 | $171,131 |
| Genentech USA, Inc. | 4 | $9,104 |
| Servier Bioinnovation | 1 | $3,740 |
| Eisai Inc. | 4 | $2,152 |
| Boehringer Ingelheim | 1 | $2,030 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,910 |
| AstraZeneca | 5 | $681 |
| Genentech, Inc. | 1 | $87 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOUNDATIONONE CDX$171,078
- FOUNDATIONONE LIQUID$36,100
- FOUNDATIONFOCUS$36,100
- FOUNDATIONONE HEME$36,100
- FOUNDATIONONE$36,100
- ASPARLAS$3,740
- TECENTRIQ$2,982
- LENVIMA$2,040
- IMFINZI$365
How this compares
$190,835 in reported general payments places this provider in the 95th percentile of 580 hematology & oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Chicago
- Michael BishopChicago$974K
- Jamile ShammoChicago$910K
- Young Kwang ChaeChicago$563K
- Irfan MirzaChicago$544K
- Marina GarassinoChicago$397K
- Chih-Yi LiaoChicago$317K
- Rita NandaChicago$286K
- Shuo MaChicago$280K
- Santosh SarafChicago$275K
- Peter RiedellChicago$273K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.